Rigel Pharmaceuticals | RIGL - Ordinary Share Capital

Stock Price
29.51
Daily Change
-0.12 -0.41%
Monthly
-13.59%
Yearly
49.80%
Q1 Forecast
33.68

Rigel Pharmaceuticals reported $17K in Ordinary Share Capital for its fiscal quarter ending in June of 2024.





Ordinary Share Capital Change Date
Agenus USD 266K 30K Mar/2025
Amgen USD 539M 1000K Dec/2025
Anika Therapeutics USD 143K 1000 Mar/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
AstraZeneca USD 1.55B 206K Dec/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Celldex Therapeutics USD 66.55M 102K Dec/2025
Daiichi Sankyo JPY 1.85B 9K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Heron Therapeutics USD 1.52M 14K Sep/2024
Intrexon USD 0 0 Jun/2024
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Karyopharm Therapeutics USD 13K 0 Sep/2024
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
MacroGenics USD 63.26M 62.63M Sep/2025
Neurocrine Biosciences USD 100.1M 400K Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Rigel Pharmaceuticals USD 17K 158K Jun/2024
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Veracyte USD 79.05M 377K Dec/2025